Parkinnova Therapeutics is dedicated to developing innovative and targeted therapies for Parkinson's disease.
Parkinnova Therapeutics has raised $398K in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Parkinnova Therapeutics's investors include Innovatiefonds Noord-Holland.
Parkinnova Therapeutics is headquartered in Amsterdam, The Netherlands.
Parkinnova Therapeutics is dedicated to developing innovative and targeted therapies for Parkinson's disease.
Parkinnova Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Parkinnova Therapeutics — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/parkinnova-therapeutics. Accessed August 1, 2026.
VCBacked. (2025). Parkinnova Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/parkinnova-therapeutics
{{cite web |title=Parkinnova Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/parkinnova-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated